The MarketWatch News Department was not involved in the creation of this content.-- Novel combinatorial oral therapy extended median remaining lifespan in adult mice by 33% compar ...
SAN FRANCISCO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Siren Biotechnology, pioneer of AAV immuno-gene therapy for cancer, today revealed its lead asset, SRN-101, for the treatment of high-grade gliomas.
SAN FRANCISCO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for cancer, today announced that the U.S. Food and Drug Administration (FDA) has ...
SRN Launches to Disrupt Youth Athletics with Affordable, Next-Generation Film Room That Levels the Playing Field for ...
Anaheim, CA (September 28, 2015) – Samsung Techwin America continues to develop solutions that deliver maximum performance and value with the release of its new NVRs at ASIS 2015 (booth # 1729).